Vanda Pharmaceuticals Inc. (United States)

Vanda Pharmaceuticals is a biopharmaceutical company focused on CNS disorders and circadian rhythm sleep-wake disorders. Based in Washington, DC, the company developed Hetlioz (tasimelteon) for non-24-hour sleep-wake disorder in blind individuals and Fanapt (iloperidone) for schizophrenia. Vanda’s neuroscience research addresses underserved psychiatric and sleep conditions.